BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21081158)

  • 1. Effect of chronic pain on morphine-induced respiratory depression in mice.
    Kamei J; Ohsawa M; Hayashi SS; Nakanishi Y
    Neuroscience; 2011 Feb; 174():224-33. PubMed ID: 21081158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 5-hydroxytryptamine 4 receptor agonist mosapride does not antagonize morphine-induced respiratory depression.
    Lötsch J; Skarke C; Schneider A; Hummel T; Geisslinger G
    Clin Pharmacol Ther; 2005 Sep; 78(3):278-87. PubMed ID: 16153398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The partial 5-hydroxytryptamine1A receptor agonist buspirone does not antagonize morphine-induced respiratory depression in humans.
    Oertel BG; Schneider A; Rohrbacher M; Schmidt H; Tegeder I; Geisslinger G; Lötsch J
    Clin Pharmacol Ther; 2007 Jan; 81(1):59-68. PubMed ID: 17186000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanism of changes in the morphine-induced pharmacological actions under chronic pain-like state: suppression of dopaminergic transmission in the brain.
    Narita M; Suzuki M; Imai S; Narita M; Ozaki S; Kishimoto Y; Oe K; Yajima Y; Yamazaki M; Suzuki T
    Life Sci; 2004 Apr; 74(21):2655-73. PubMed ID: 15041447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of morphine, methadone and heroin induced effects in mice by naloxone methiodide.
    Lewanowitsch T; Miller JH; Irvine RJ
    Life Sci; 2006 Jan; 78(7):682-8. PubMed ID: 16102783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of peripheral morphine analgesia contributes to the reduced effectiveness of systemic morphine in neuropathic pain.
    Rashid MH; Inoue M; Toda K; Ueda H
    J Pharmacol Exp Ther; 2004 Apr; 309(1):380-7. PubMed ID: 14718584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The counteraction of opioid-induced ventilatory depression by the serotonin 1A-agonist 8-OH-DPAT does not antagonize antinociception in rats in situ and in vivo.
    Guenther U; Manzke T; Wrigge H; Dutschmann M; Zinserling J; Putensen C; Hoeft A
    Anesth Analg; 2009 Apr; 108(4):1169-76. PubMed ID: 19299781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 5-HT4 agonist, mosapride, enhances intrinsic rectorectal and rectoanal reflexes after removal of extrinsic nerves in guinea pigs.
    Kojima Y; Nakagawa T; Katsui R; Fujii H; Nakajima Y; Takaki M
    Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G351-60. PubMed ID: 15817810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid-induced respiratory depression: are 5-HT4a receptor agonists the cure?
    Eilers H; Schumacher MA
    Mol Interv; 2004 Aug; 4(4):197-9. PubMed ID: 15304555
    [No Abstract]   [Full Text] [Related]  

  • 11. Repinotan, a selective 5-HT1A-R-agonist, antagonizes morphine-induced ventilatory depression in anesthetized rats.
    Guenther U; Wrigge H; Theuerkauf N; Boettcher MF; Wensing G; Zinserling J; Putensen C; Hoeft A
    Anesth Analg; 2010 Oct; 111(4):901-7. PubMed ID: 20802053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 5-HT4 receptor agonist mosapride attenuates inflammation of reflux esophagitis.
    Zhuang ZH; Zou FM; Tang DP; Zhuang JY; Wei JJ; Yang LY
    Hepatogastroenterology; 2014; 61(129):115-9. PubMed ID: 24895805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment with antiserum against dynorphin, substance P, or cholecystokinin enhances the morphine-produced anti-allodynia in the sciatic nerve ligated mice.
    Wu HE; Schwasinger ET; Hong JS; Tseng LF
    Neurosci Lett; 2005 Sep; 386(1):46-51. PubMed ID: 15982809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro enhanced differentiation of neural networks in ES gut-like organ from mouse ES cells by a 5-HT4-receptor activation.
    Takaki M; Misawa H; Matsuyoshi H; Kawahara I; Goto K; Zhang GX; Obata K; Kuniyasu H
    Biochem Biophys Res Commun; 2011 Mar; 406(4):529-33. PubMed ID: 21333625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of effect of mosapride citrate and existing 5-HT4 receptor agonists on gastrointestinal motility in vivo and in vitro.
    Mine Y; Yoshikawa T; Oku S; Nagai R; Yoshida N; Hosoki K
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1000-8. PubMed ID: 9399969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of selective NK(1) receptor antagonist CI-1021 in animal models of inflammatory and neuropathic pain.
    Gonzalez MI; Field MJ; Hughes J; Singh L
    J Pharmacol Exp Ther; 2000 Aug; 294(2):444-50. PubMed ID: 10900217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 5-HT4 agonist mosapride enhances rectorectal and rectoanal reflexes in guinea pigs.
    Shimatani H; Kojima Y; Kadowaki M; Nakagawa T; Fujii H; Nakajima Y; Takaki M
    Am J Physiol Gastrointest Liver Physiol; 2003 Aug; 285(2):G389-95. PubMed ID: 12724131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
    Boronat MA; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JNJ-20788560 [9-(8-azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-3-carboxylic acid diethylamide], a selective delta opioid receptor agonist, is a potent and efficacious antihyperalgesic agent that does not produce respiratory depression, pharmacologic tolerance, or physical dependence.
    Codd EE; Carson JR; Colburn RW; Stone DJ; Van Besien CR; Zhang SP; Wade PR; Gallantine EL; Meert TF; Molino L; Pullan S; Razler CM; Dax SL; Flores CM
    J Pharmacol Exp Ther; 2009 Apr; 329(1):241-51. PubMed ID: 19151246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effects of caffeine on the respiratory depression by morphine].
    Kasaba T; Takeshita M; Takasaki M
    Masui; 1997 Dec; 46(12):1570-4. PubMed ID: 9455078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.